Type 2 diabetes linked to colorectal cancer risk in men

(HealthDay)—Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the&n

Updated on: March 14,2024

Type 2 diabetes linked to colorectal cancer risk in men

(HealthDay)—Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the&n

Updated on:March 14,2024

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on: May 11,2024

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on:May 11,2024

New research discovers new cause of cancer coming from inside us

byFlinders UniversityHusband and wife Professor Simon Conn and Dr Vanessa Conn’s team at the Flinders Centre for Innovation in Cancer has been researching the role of circular RNAs in DNA damage

Updated on: January 12,2024

New research discovers new cause of cancer coming from inside us

byFlinders UniversityHusband and wife Professor Simon Conn and Dr Vanessa Conn’s team at the Flinders Centre for Innovation in Cancer has been researching the role of circular RNAs in DNA damage

Updated on:January 12,2024

New CAR-T cells offer on-demand control for cancer treatment

byLudwig Cancer ResearchCredit: Pixabay/CC0 Public DomainLudwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that c

Updated on: November 09,2024

New CAR-T cells offer on-demand control for cancer treatment

byLudwig Cancer ResearchCredit: Pixabay/CC0 Public DomainLudwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that c

Updated on:November 09,2024

Scientists develop new model for ovarian cancer, with crossover to uterine cancer

by Leslie Cantu,Medical University of South CarolinaAlexandra Blackman, M.D., was a gynecologic oncology fellow in the lab of Joe Delaney, Ph.D., right, at the time of this photo. She is first a

Updated on: November 11,2024

Scientists develop new model for ovarian cancer, with crossover to uterine cancer

by Leslie Cantu,Medical University of South CarolinaAlexandra Blackman, M.D., was a gynecologic oncology fellow in the lab of Joe Delaney, Ph.D., right, at the time of this photo. She is first a

Updated on:November 11,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on: February 20,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on:February 20,2024

Study reveals root of triple negative breast cancer immunosuppression and chemoresistance

by Hokkaido UniversityIn IL-34-expressing tumors, blood vessels were observed only in the outer layer, whereas in IL-34-deficient tumors, blood vessels were observed in the whole area (modified f

Updated on: February 20,2024

Study reveals root of triple negative breast cancer immunosuppression and chemoresistance

by Hokkaido UniversityIn IL-34-expressing tumors, blood vessels were observed only in the outer layer, whereas in IL-34-deficient tumors, blood vessels were observed in the whole area (modified f

Updated on:February 20,2024

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat

Updated on: December 28,2023

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat

Updated on:December 28,2023

New insight into aggressive breast cancers

by Cardiff UniversityCredit: CC0 Public DomainScientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improv

Updated on: March 06,2024

New insight into aggressive breast cancers

by Cardiff UniversityCredit: CC0 Public DomainScientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improv

Updated on:March 06,2024

17-gene signature linked to remission after triple-negative breast cancer treatment

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainMayo Clinic researchers have discovered a distinctive pattern in a specific set of 17 genes that may be associated with remission after treatm

Updated on: March 14,2024

17-gene signature linked to remission after triple-negative breast cancer treatment

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainMayo Clinic researchers have discovered a distinctive pattern in a specific set of 17 genes that may be associated with remission after treatm

Updated on:March 14,2024

Researchers develop AI model to improve tumor removal accuracy during breast cancer surgery

by University of North Carolina at Chapel Hill School of Medicine(A) Diagram of model structure. (B) Flowchart of study design. Credit:Annals of Surgical Oncology(2023). DOI: 10.1245/

Updated on: January 30,2024

Researchers develop AI model to improve tumor removal accuracy during breast cancer surgery

by University of North Carolina at Chapel Hill School of Medicine(A) Diagram of model structure. (B) Flowchart of study design. Credit:Annals of Surgical Oncology(2023). DOI: 10.1245/

Updated on:January 30,2024

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Updated on: September 27,2024

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Updated on:September 27,2024